CLASS II Device recall · Reported 17 Jun 2020 · FDA Enforcement Report

Histoplasma Immunodiffusion (ID) Antigen recalled by Immuno-Mycologics

Immuno-Mycologics is recalling Histoplasma Immunodiffusion (ID) Antigen, distributed nationwide in the US. The recall was initiated on 4 Nov 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot number L106909; UDI # (01) 00816387020391 (17) 220610(10)L106909
Quantity recalled155 vials

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2301-2020
FDA event ID
85368
Recalling firm
Immuno-Mycologics, Norman, OK
Classification
Class II
Status
Terminated
Recall initiated
4 Nov 2019
FDA classified
9 Jun 2020
Reported
17 Jun 2020
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

4 Nov 2019Recall initiated by company
9 Jun 2020Classified by FDA+218 days
17 Jun 2020Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

False positive results due to potential contamination of reagent.

Product as listed by the FDA

Histoplasma Immunodiffusion (ID) Antigen; The IFU labeling is for multiple products which included Fungal Antigens, Positive Controls and ID Plates,and Immunodiffusion (ID) Plates for use in the ID Test, Histoplasma ID Antigen

Where it was distributed

Worldwide distribution - US Nationwide distribution including in the states of AZ, CA, FL, IL, IN, MI, MN, NY,TX, UT, VA, WI and the countries of France, Spain, Hong Kong, United Kingdom.

Nationwide ArizonaCaliforniaFloridaIllinoisIndianaMichiganMinnesotaNew YorkTexasUtahVirginiaWisconsin

Questions about this recall

Why was it recalled?

False positive results due to potential contamination of reagent.

Which lots are affected?

Lot number L106909; UDI # (01) 00816387020391 (17) 220610(10)L106909

Where was it sold?

Worldwide distribution - US Nationwide distribution including in the states of AZ, CA, FL, IL, IN, MI, MN, NY,TX, UT, VA, WI and the countries of France, Spain, Hong Kong, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Immuno-Mycologics

All 7

Other Test Kits & Diagnostics recalls

All 2,663